Southern Petrochemicals Industries Corporation Ltd (SPIC): Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 12, 2025, 12:27 pm

Quick Insight

Southern Petrochemicals Industries Corporation Ltd (SPIC) currently trades at a price of 110 with a market capitalization of 2,248 Cr. The company's P/E ratio stands at 14.1, indicating a moderately priced stock. With a respectable ROE of 13.8% and a robust ROCE of 16.9%, SPIC demonstrates efficient capital utilization. The operational performance, reflected in an OPM of 12%, seems steady. However, the company's borrowings of 722 Cr and CCC of -23 days raise concerns about liquidity and leverage. Shareholders' composition shows a significant promoter holding of 53.38%. Overall, while SPIC shows promise with its financial metrics, investors should closely monitor its debt levels and working capital management for sustained growth.

Competitors of Southern Petrochemicals Industries Corporation Ltd (SPIC)

All Competitor Stocks of Southern Petrochemicals Industries Corporation Ltd (SPIC)

Quarterly Result

Last Updated: August 20, 2025, 3:15 am

Below is a detailed analysis of the quarterly data for Southern Petrochemicals Industries Corporation Ltd (SPIC) based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 781.00 Cr.. The value appears strong and on an upward trend. It has increased from 754.00 Cr. (Mar 2025) to 781.00 Cr., marking an increase of 27.00 Cr..
• For Expenses, as of Jun 2025, the value is 687.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 718.00 Cr. (Mar 2025) to 687.00 Cr., marking a decrease of 31.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 56.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Mar 2025) to 12.00%, marking an increase of 7.00%.
• For Other Income, as of Jun 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 15.00 Cr..
• For Interest, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 71.00 Cr..
• For Tax %, as of Jun 2025, the value is 34.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Mar 2025) to 34.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 48.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.28. The value appears strong and on an upward trend. It has increased from 0.96 (Mar 2025) to 3.28, marking an increase of 2.32.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:58 pm

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: September 10, 2025, 2:33 pm

Below is a detailed analysis of the balance sheet data for Southern Petrochemicals Industries Corporation Ltd (SPIC) based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 204.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 204.00 Cr..
• For Reserves, as of Mar 2025, the value is 995.00 Cr.. The value appears strong and on an upward trend. It has increased from 872.00 Cr. (Mar 2024) to 995.00 Cr., marking an increase of 123.00 Cr..
• For Borrowings, as of Mar 2025, the value is 722.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 471.00 Cr. (Mar 2024) to 722.00 Cr., marking an increase of 251.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 366.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 218.00 Cr. (Mar 2024) to 366.00 Cr., marking an increase of 148.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,287.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,764.00 Cr. (Mar 2024) to 2,287.00 Cr., marking an increase of 523.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 620.00 Cr.. The value appears to be declining and may need further review. It has decreased from 652.00 Cr. (Mar 2024) to 620.00 Cr., marking a decrease of 32.00 Cr..
• For CWIP, as of Mar 2025, the value is 108.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 108.00 Cr., marking an increase of 74.00 Cr..
• For Investments, as of Mar 2025, the value is 252.00 Cr.. The value appears strong and on an upward trend. It has increased from 225.00 Cr. (Mar 2024) to 252.00 Cr., marking an increase of 27.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,307.00 Cr.. The value appears strong and on an upward trend. It has increased from 853.00 Cr. (Mar 2024) to 1,307.00 Cr., marking an increase of 454.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,287.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,764.00 Cr. (Mar 2024) to 2,287.00 Cr., marking an increase of 523.00 Cr..

Notably, the Reserves (995.00 Cr.) exceed the Borrowings (722.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Southern Petrochemicals Industries Corporation Ltd (SPIC), here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.64. This value is within the healthy range. It has increased from 5.55 (Mar 24) to 7.64, marking an increase of 2.09.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.64. This value is within the healthy range. It has increased from 5.55 (Mar 24) to 7.64, marking an increase of 2.09.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.90. This value is within the healthy range. It has increased from 6.10 (Mar 24) to 7.90, marking an increase of 1.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 58.87. It has increased from 52.82 (Mar 24) to 58.87, marking an increase of 6.05.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 58.87. It has increased from 52.82 (Mar 24) to 58.87, marking an increase of 6.05.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.56. It has increased from 95.45 (Mar 24) to 151.56, marking an increase of 56.11.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.50. This value is within the healthy range. It has increased from 13.15 (Mar 24) to 14.50, marking an increase of 1.35.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.65. This value is within the healthy range. It has increased from 11.27 (Mar 24) to 12.65, marking an increase of 1.38.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.95. This value is within the healthy range. It has increased from 7.02 (Mar 24) to 9.95, marking an increase of 2.93.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.05. This value is within the healthy range. It has increased from 4.22 (Mar 24) to 6.05, marking an increase of 1.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.64. This value is within the healthy range. It has increased from 5.55 (Mar 24) to 7.64, marking an increase of 2.09.
• For PBDIT Margin (%), as of Mar 25, the value is 9.56. This value is below the healthy minimum of 10. It has decreased from 13.77 (Mar 24) to 9.56, marking a decrease of 4.21.
• For PBIT Margin (%), as of Mar 25, the value is 8.34. This value is below the healthy minimum of 10. It has decreased from 11.81 (Mar 24) to 8.34, marking a decrease of 3.47.
• For PBT Margin (%), as of Mar 25, the value is 6.56. This value is below the healthy minimum of 10. It has decreased from 7.35 (Mar 24) to 6.56, marking a decrease of 0.79.
• For Net Profit Margin (%), as of Mar 25, the value is 3.99. This value is below the healthy minimum of 5. It has decreased from 4.42 (Mar 24) to 3.99, marking a decrease of 0.43.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.04. This value is below the healthy minimum of 8. It has decreased from 5.81 (Mar 24) to 5.04, marking a decrease of 0.77.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.98. This value is below the healthy minimum of 15. It has increased from 10.51 (Mar 24) to 12.98, marking an increase of 2.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.64. This value is within the healthy range. It has decreased from 20.12 (Mar 24) to 18.64, marking a decrease of 1.48.
• For Return On Assets (%), as of Mar 25, the value is 6.81. This value is within the healthy range. It has increased from 6.41 (Mar 24) to 6.81, marking an increase of 0.40.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.11, marking an increase of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.59. This value is within the healthy range. It has increased from 0.43 (Mar 24) to 0.59, marking an increase of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.52. It has increased from 0.98 (Mar 24) to 1.52, marking an increase of 0.54.
• For Current Ratio (X), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 1.5. It has increased from 0.92 (Mar 24) to 1.00, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has increased from 0.77 (Mar 24) to 0.91, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 26.45. This value exceeds the healthy maximum of 8. It has increased from 8.09 (Mar 24) to 26.45, marking an increase of 18.36.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 27.02 (Mar 24) to 0.00, marking a decrease of 27.02.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.19 (Mar 24) to 0.00, marking a decrease of 20.19.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 72.98 (Mar 24) to 0.00, marking a decrease of 72.98.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.81 (Mar 24) to 0.00, marking a decrease of 79.81.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 7.05 (Mar 24) to 5.37, marking a decrease of 1.68.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.24. This value is within the healthy range. It has decreased from 4.54 (Mar 24) to 3.24, marking a decrease of 1.30.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,313.68. It has increased from 1,721.76 (Mar 24) to 2,313.68, marking an increase of 591.92.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 24) to 0.74, marking a decrease of 0.14.
• For EV / EBITDA (X), as of Mar 25, the value is 7.83. This value is within the healthy range. It has increased from 6.43 (Mar 24) to 7.83, marking an increase of 1.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 24) to 0.53, marking a decrease of 0.20.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 72.97 (Mar 24) to 0.00, marking a decrease of 72.97.
• For Price / BV (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has increased from 1.33 (Mar 24) to 1.37, marking an increase of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 24) to 0.53, marking a decrease of 0.20.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.09, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness